OSCR
Income statement / Annual
Last year (2025), Oscar Health Inc's total revenue was $11.70 B,
an increase of 27.50% from the previous year.
In 2025, Oscar Health Inc's net income was -$443.15 M.
See Oscar Health Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$11.70 B |
$9.18 B |
$5.86 B |
$4.13 B |
$1.92 B |
$589.64 M |
$553.78 M |
| Cost of Revenue |
$10.02 B
|
$7.33 B
|
$4.64 B
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$1.68 B
|
$1.84 B
|
$1.22 B
|
$4.13 B
|
$1.92 B
|
$589.64 M
|
$553.78 M
|
| Gross Profit Ratio |
0.14
|
0.2
|
0.21
|
1
|
1
|
1
|
1
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$2.05 B
|
$0.00
|
$0.00
|
$1.42 B
|
$265.08 M
|
$166.66 M
|
$110.68 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$2.05 B
|
$0.00
|
$0.00
|
$1.42 B
|
$265.08 M
|
$166.66 M
|
$110.68 M
|
| Other Expenses |
$28.89 M
|
$1.79 B
|
$1.46 B
|
$3.32 B
|
$2.23 B
|
$828.77 M
|
$702.49 M
|
| Operating Expenses |
$2.08 B
|
$1.79 B
|
$1.46 B
|
$4.74 B
|
$2.49 B
|
$995.42 M
|
$813.17 M
|
| Cost And Expenses |
$12.10 B
|
$9.12 B
|
$6.10 B
|
$4.74 B
|
$2.49 B
|
$995.42 M
|
$813.17 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$11.12 M
|
| Interest Expense |
$17.60 M
|
$23.73 M
|
$24.60 M
|
$22.62 M
|
$4.72 M
|
$3.51 M
|
$0.00
|
| Depreciation & Amortization |
$28.89 M
|
$32.15 M
|
$30.69 M
|
$15.28 M
|
$14.61 M
|
$11.29 M
|
$6.90 M
|
| EBITDA |
-$391.05 M |
$89.31 M |
-$212.00 M |
-$572.17 M |
-$551.26 M |
-$390.98 M |
-$252.49 M |
| EBITDA Ratio |
-0.03
|
0.01
|
-0.04
|
-0.14
|
-0.29
|
-0.66
|
-0.46
|
| Operating Income Ratio |
-0.03
|
0.01
|
-0.04
|
-0.15
|
-0.3
|
-0.69
|
-0.47
|
| Total Other Income/Expenses Net |
-$40.94 M
|
-$23.84 M
|
-$31.69 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Income Before Tax |
-$437.30 M
|
$33.43 M
|
-$267.30 M
|
-$610.08 M
|
-$570.58 M
|
-$405.78 M
|
-$259.39 M
|
| Income Before Tax Ratio |
-0.04
|
0
|
-0.05
|
-0.15
|
-0.3
|
-0.69
|
-0.47
|
| Income Tax Expense |
$5.61 M
|
$7.31 M
|
$3.29 M
|
-$523.00 K
|
$846.00 K
|
$1.05 M
|
$1.79 M
|
| Net Income |
-$443.15 M
|
$25.43 M
|
-$270.73 M
|
-$606.28 M
|
-$572.61 M
|
-$406.83 M
|
-$261.18 M
|
| Net Income Ratio |
-0.04
|
0
|
-0.05
|
-0.15
|
-0.3
|
-0.69
|
-0.47
|
| EPS |
-1.69 |
0.11 |
-1.22 |
-2.85 |
-3.19 |
-1.7 |
-8.93 |
| EPS Diluted |
-1.69 |
0.0957 |
-1.22 |
-2.85 |
-3.19 |
-1.7 |
-1.09 |
| Weighted Average Shares Out |
$262.39 M
|
$240.39 M
|
$221.66 M
|
$212.47 M
|
$178.97 M
|
$239.31 M
|
$29.26 M
|
| Weighted Average Shares Out Diluted |
$262.39 M
|
$265.85 M
|
$221.66 M
|
$212.47 M
|
$178.97 M
|
$239.31 M
|
$239.31 M
|
| Link |
|
|
|
|
|
|
|
